Search results for "Cognitive"

showing 10 items of 10389 documents

2018

Insomnia and obstructive sleep apnea (OSA) are often both present in patients with sleep-disordered-breathing (SDB). The coexistence of the two disorders shows an increase in cumulative morbidity and an overall greater illness severity. There is still considerable controversy regarding management decisions in this group of patients. This systematic review focused on more recent evidence regarding treatment of patients presenting with both clinical entities of comorbid insomnia and OSA (COMISA) in terms of their management, especially using combinations of positive airway pressure [PAP, namely aPAP, cPAP, adaptive servo-ventilation (ASV)] and CBTi as well as each one of these two modalities …

medicine.medical_specialtyModalitiesComorbid insomniabusiness.industrymedicine.medical_treatmentSleep apneamedicine.diseasenervous system diseasesrespiratory tract diseasesCognitive behavioral therapyObstructive sleep apnea03 medical and health sciences0302 clinical medicine030228 respiratory systemNeurologymental disordersPositive airway pressureInsomniaMedicineIn patientNeurology (clinical)medicine.symptombusinessIntensive care medicine030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

Monitoring stress and recovery states: Structural and external stages of the short version of the RESTQ sport in elite swimmers before championships

2016

Background: Psychological stress and recovery monitoring is a key issue for increasing athletes' health, well-being, and performance. This multi-study report examined changes and the dose–response relationships between recovery–stress psychological states, training load (TL), heart rate (HR), heart rate recovery (HRR), and heart rate variability (HRV) while providing evidence for the factorial validity of a short French version of the Recovery–Stress Questionnaire for Athletes (RESTQ-36-R-Sport). Methods: Four hundred and seventy-three university athletes (Study 1), 72 full expert swimmers (Study 2), and 11 national to international swimmers (Study 3) participated in the study. Data were an…

medicine.medical_specialtyMonitoringPhysical Therapy Sports Therapy and Rehabilitation[ SCCO.PSYC ] Cognitive science/PsychologyStressConfirmatory factor analysislcsh:GV557-1198.99503 medical and health sciences0302 clinical medicineRecoveryHeart ratemedicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Heart rate variabilityOrthopedics and Sports MedicineCompetitive sportlcsh:Sports medicineChampionshipAdaptationHeart rate variabilityComputingMilieux_MISCELLANEOUSMaladaptationlcsh:Sports[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]030229 sport sciencesConfirmatory factor analysis[SCCO.PSYC]Cognitive science/PsychologyPhysical therapyOriginal ArticleAnalysis of variancelcsh:RC1200-1245Training programPsychologyhuman activities030217 neurology & neurosurgery
researchProduct

2017

This study investigated the role of vection (i.e., a visually induced sense of self-motion), optokinetic nystagmus (OKN), and inadvertent head movements in visually induced motion sickness (VIMS), evoked by yaw rotation of the visual surround. These three elements have all been proposed as contributing factors in VIMS, as they can be linked to different motion sickness theories. However, a full understanding of the role of each factor is still lacking because independent manipulation has proven difficult in the past. We adopted an integrative approach to the problem by obtaining measures of potentially relevant parameters in four experimental conditions and subsequently combining them in a …

medicine.medical_specialtyMultidisciplinary05 social sciencesYawEye movementSensory systemOptokinetic reflexmedicine.disease050105 experimental psychology03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMotion sicknessFixation (visual)Motion directionmedicineHead movements0501 psychology and cognitive sciencesPsychology030217 neurology & neurosurgeryPLOS ONE
researchProduct

2013

Purpose This study assessed, for the first time, prevalence estimates for physical and cognitive doping within a single collective of athletes using the randomized response technique (RRT). Furthermore, associations between the use of legal and freely available substances to improve physical and cognitive performance (enhancement) and illicit or banned substances to improve physical and cognitive performance (doping) were examined. Methods An anonymous questionnaire using the unrelated question RRT was used to survey 2,997 recreational triathletes in three sports events (Frankfurt, Regensburg, and Wiesbaden) in Germany. Prior to the survey, statistical power analyses were performed to deter…

medicine.medical_specialtyMultidisciplinarybiologyAthletesCross-sectional studybusiness.industryCognitionmedicine.diseaseLogistic regressionbiology.organism_classificationRecreational drug useSubstance abusemedicinePerformance-Enhancing SubstancesEffects of sleep deprivation on cognitive performancePsychiatrybusinesshuman activitiesClinical psychologyPLOS ONE
researchProduct

2021

BackgroundExecutive functions underlie self-regulation and are thus important for physical activity and adaptation to new situations. The aim was to investigate, if yearlong physical and cognitive training (PTCT) had greater effects on physical activity among older adults than physical training (PT) alone, and if executive functions predicted physical activity at baseline, after six (6m) and twelve months (12m) of the interventions, one-year post-intervention follow-up and an extended follow-up during COVID-19 lockdown.MethodsData from a single-blinded, parallel-group randomized controlled trial (PASSWORD-study, ISRCTN52388040) were utilized. Participants were 70–85 years old community-dwel…

medicine.medical_specialtyMultidisciplinarybusiness.industryTrail Making TestPsychological interventionExecutive functionsCognitive traininglaw.invention03 medical and health sciencesFluency0302 clinical medicineRandomized controlled triallawIntervention (counseling)Physical therapyMedicine030212 general & internal medicinebusiness030217 neurology & neurosurgeryStroop effectPLOS ONE
researchProduct

2018

Purpose: There is some controversy whether or not saccades change with age. This cross-sectional study aims to clarify the characteristics of reflexive saccades at various ages to establish a normative cohort in a standardized set-up. Second objective is to investigate the feasibility of saccadometry in daily ophthalmological practice. Methods: One hundred healthy participants aged between 6 and 76 years underwent an ophthalmologic examination and saccadometry, using an infrared video-oculography device, sampling at 220 Hz. The reflexive saccades were evoked in four directions and three target displacements each (5°/15°/30° horizontally and of 5°/10°/20° vertically). Saccadic peak velocity,…

medicine.medical_specialtyMultidisciplinarymedia_common.quotation_subject05 social sciencesEye movementIsometric exerciseAudiologyDisplacement (psychology)050105 experimental psychologySaccadic masking03 medical and health sciences0302 clinical medicineAmplitudeFixation (visual)medicine0501 psychology and cognitive sciencesEccentricity (behavior)Latency (engineering)030217 neurology & neurosurgerymedia_commonMathematicsPLOS ONE
researchProduct

Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown

2020

Objective: The effects of the COVID-19 lockdown on subjects with prodromal phases of dementia are unknown. The aim of this study was to evaluate the motor, cognitive, and behavioral changes during the COVID-19 lockdown in Italy in patients with Parkinson's disease (PD) with and without mild cognitive impairment (PD-MCI and PD-NC) and in patients with MCI not associated with PD (MCInoPD).Methods: A total of 34 patients with PD-NC, 31 PD-MCI, and 31 MCInoPD and their caregivers were interviewed 10 weeks after the COVID-19 lockdown in Italy, and changes in cognitive, behavioral, and motor symptoms were examined. Modified standardized scales, including the Neuropsychiatric Inventory (NPI) and t…

medicine.medical_specialtyMultivariate analysisActivities of daily livingParkinson's diseaselcsh:RC435-571behavioral symptomsParkinson's diseaseDiseasebehavioral symptoms caregiver burden cognitive impairment COVID-19 motor impairment Parkinson's disease quarantinemotor impairment03 medical and health sciences0302 clinical medicineRating scalelcsh:PsychiatryInternal medicinemental disordersmedicineDementiaOriginal Researchcognitive impairmentPsychiatrycaregiver burden030214 geriatricsbusiness.industryquarantineCOVID-19CognitionCaregiver burdenmedicine.diseasePsychiatry and Mental healthbusiness030217 neurology & neurosurgeryFrontiers in Psychiatry
researchProduct

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

2014

Anxiety and depressive disorders are characterized by a number of clinical symptoms like decreased mood, apathy, anhedonia and anxiety. An important element of the clinical picture is also neurocognitive impairment. The most common treatment methods for depression and anxiety are pharmacology, psychotherapy or a combination of both methods. The data from literature show that those treatment methods lead to an improvement of clinical symptoms, but they exert a possible impact on cognitive functions. However the study results referring both to the role of pharmacological treatment and psychotherapy in this domain are still inconsistent. There is an increasing number of accessible data confirm…

medicine.medical_specialtyNeurologyClinical NeurologyPsychological interventionAnxietyPsychiatry and Preclinical Psychiatric Studies - Review articlemedicineHumansApathyCognitive skillPsychiatryBiological PsychiatryPsychotropic DrugsDepressionAnhedoniaCognitionAnxiety DisordersDatabases BibliographicPharmacotherapyCognitive functionsPsychotherapyPsychiatry and Mental healthNeurologyAnxietyNeurology (clinical)medicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologyJournal of Neural Transmission : Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies
researchProduct

The capacity to consent to treatment in amyotrophic lateral sclerosis: a preliminary report

2020

Background: Facing the relentless worsening of their condition, ALS patients are required to make decisions on treatments and end-of-life care. A cognitive impairment showed to be a negative prognostic factor in ALS patients, perhaps affecting the ability to make informed decisions. Notwithstanding its crucial role, the capacity to consent to treatment (CCT) has never been evaluated in these patients. Objectives: To assess the CCT in an ALS cohort in comparison to a control group, and to study the effects of demographic and clinical variables on this high-level cognitive function. Methods: 102 ALS patients and 106 healthy controls (HC) were enrolled. CCT was assessed using the MacArthur Com…

medicine.medical_specialtyNeurologygenetic structuresDiseaseNeuropsychological TestsAffect (psychology)03 medical and health sciencesCognition0302 clinical medicinemedicineHumans030212 general & internal medicineAmyotrophic lateral sclerosisAmyotrophic lateral sclerosiDepression (differential diagnoses)Informed Consentbusiness.industryAmyotrophic Lateral SclerosisNeuropsychologyCognitionmedicine.diseaseeye diseases3. Good healthCognitive impairmentNeurologyCohortNeuropsychological Testsense organsNeurology (clinical)Cognition Disordersbusiness030217 neurology & neurosurgeryDecision-makingHumanClinical psychologyJournal of Neurology
researchProduct

Towards a framework for treatment effectiveness in schizophrenia

2014

Georg Juckel,1 Andrea de Bartolomeis,2 Philip Gorwood,3 Sergey Mosolov,4 Luca Pani,5 Alessandro Rossi,6 Julio Sanjuan7 1Department of Psychiatry, LWL-University Hospital, Ruhr-University Bochum, Bochum, Germany; 2Laboratory of Molecular Psychiatry and Unit of Treatment Resistant Psychosis, University School of Medicine of Naples Federico II, Napoli, Italy; 3Groupe Hospitalier Sainte-Anne (CMME), Paris-Descartes University, Paris, France; 4Moscow Research Institute of Psychiatry, Moscow, Russia; 5Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy; 6Università de L’Aquila, L’Aquila, Italy; 7Clinic Hospital, Spanish Mental Hea…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmentAlternative medicineSatisfactionNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAntipsychoticAssessment scaleExtrapyramidal symptomsmedicineFunctioningCognitive skillAntipsychoticPsychiatryRC346-429Biological PsychiatryDisease burdenOriginal Researchassessment scalesbusiness.industryMental illneMental illnessmedicine.diseasemental illnessAntipsychotic; Assessment scales; Functioning; Mental illness; SatisfactionPsychiatry and Mental HealthMental illnessSchizophreniaNeurology. Diseases of the nervous systemmedicine.symptombusinessAssessment scalesRC321-571Neuropsychiatric Disease and Treatment
researchProduct